Pfizer was founded in 1849 in New York by cousins and German immigrants Charles Pfizer and Charles Erhart. Pfizer was also a pioneer in the production of antibiotics.
As we can see in the company's history, today it has in its portfolio around 100 products in different therapeutic classes for the treatment of various diseases.
Speaking of a Global school, the company has 46 industrial units, distributed across 150 countries, with the collaboration of 81.9 thousand employees.
Furthermore, according to Wikipedia information, today the company has significant investments and cutting-edge technology for the discovery and study of new drugs, Pfizer is recognized for its innovation. Currently, the company maintains six research centers for new molecules in the United States and one in England.
Pfizer is a pharmaceutical giant
Currently, thousands of scientists and researchers are involved in the development of new therapies for cardiovascular diseases, central nervous system diseases, men's and women's health and the treatment of complex diseases, such as cancer and AIDS.
In addition to this, it works on the development and marketing of products for human health, and the company has a division dedicated to animal health.
Pfizer's operations in Brazil
In Brazil, Pfizer is a leader in several therapeutic segments and exports its products to 60 countries on all continents. It arrived in Brazil in 1952. The company currently has 1,900 employees, distributed among its headquarters in São Paulo, a manufacturing unit in Itapevi and offices in several Brazilian capitals.
Pfizer also includes social actions, because it understands that this is a key sector in social development.
You know that in Brazil, the company invests in social projects and programs to encourage volunteering, focused on health education and community reintegration.
Pfizer announces coronavirus vaccine
Pfizer has just announced important advances in the battle against the global COVID-19 pandemic. The company's efforts are focused on both treating the disease and possibly preventing the novel coronavirus (Sars-Cov-2), using a vaccine candidate whose clinical program is expected to begin in the coming weeks.
The company is committed to making the impossible possible, so we have hope, because after all, we are talking about a giant, right? We have no reason to despair, but that's not all. The company also said:
We are collaborating with partners in the healthcare sector and academic institutions to develop potential new approaches to prevent and treat COVID-19.
They warned: “Our researchers and scientists are also exploring potential new uses of existing medicines in the company's portfolio to help infected patients,” said Pfizer's global CEO, Albert Bourla.
So, did you like it? Then share it, because it is important for our work!
Source: Pharma Portal